97 related articles for article (PubMed ID: 30037821)
21. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons.
Wolfart J; Neuhoff H; Franz O; Roeper J
J Neurosci; 2001 May; 21(10):3443-56. PubMed ID: 11331374
[TBL] [Abstract][Full Text] [Related]
22. The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
Steinestel K; Eder S; Ehinger K; Schneider J; Genze F; Winkler E; Wardelmann E; Schrader AJ; Steinestel J
Tumour Biol; 2016 May; 37(5):6275-83. PubMed ID: 26619845
[TBL] [Abstract][Full Text] [Related]
23. No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia.
Bonnet-Brilhault F; Laurent C; Campion D; Thibaut F; Lafargue C; Charbonnier F; Deleuze JF; Ménard JF; Jay M; Petit M; Frebourg T; Mallet J
Eur J Hum Genet; 1999; 7(2):247-50. PubMed ID: 10196711
[TBL] [Abstract][Full Text] [Related]
24. Orai1 forms a signal complex with SK3 channel in gallbladder smooth muscle.
Song K; Zhong XG; Xia XM; Huang JH; Fan YF; Yuan RX; Xue NR; Du J; Han WX; Xu AM; Shen B
Biochem Biophys Res Commun; 2015 Oct; 466(3):456-62. PubMed ID: 26367175
[TBL] [Abstract][Full Text] [Related]
25. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
26. Screening of KCNN3 in patients with early-onset lone atrial fibrillation.
Olesen MS; Jabbari J; Holst AG; Nielsen JB; Steinbrüchel DA; Jespersen T; Haunsø S; Svendsen JH
Europace; 2011 Jul; 13(7):963-7. PubMed ID: 21398315
[TBL] [Abstract][Full Text] [Related]
27. Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
Rizzo R; Spaggiari F; Indelli M; Lelli G; Baricordi OR; Rimessi P; Ferlini A
Breast Cancer Res Treat; 2010 Nov; 124(2):593-8. PubMed ID: 20632082
[TBL] [Abstract][Full Text] [Related]
28. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
29. Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21.
Antonarakis SE; Blouin JL; Lasseter VK; Gehrig C; Radhakrishna U; Nestadt G; Housman DE; Kazazian HH; Kalman K; Gutman G; Fantino E; Chandy KG; Gargus JJ; Pulver AE
Am J Med Genet; 1999 Aug; 88(4):348-51. PubMed ID: 10402501
[TBL] [Abstract][Full Text] [Related]
30. Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia.
Tomita H; Shakkottai VG; Gutman GA; Sun G; Bunney WE; Cahalan MD; Chandy KG; Gargus JJ
Mol Psychiatry; 2003 May; 8(5):524-35, 460. PubMed ID: 12808432
[TBL] [Abstract][Full Text] [Related]
31. Small-conductance calcium-activated K+ channels are expressed in pancreatic islets and regulate glucose responses.
Tamarina NA; Wang Y; Mariotto L; Kuznetsov A; Bond C; Adelman J; Philipson LH
Diabetes; 2003 Aug; 52(8):2000-6. PubMed ID: 12882916
[TBL] [Abstract][Full Text] [Related]
32. Association analysis of CAG repeats at the KCNN3 locus in Indian patients with bipolar disorder and schizophrenia.
Saleem Q; Sreevidya VS; Sudhir J; Savithri JV; Gowda Y; B-Rao C; Benegal V; Majumder PP; Anand A; Brahmachari SK; Jain S
Am J Med Genet; 2000 Dec; 96(6):744-8. PubMed ID: 11121173
[TBL] [Abstract][Full Text] [Related]
33. Small-conductance, calcium-activated potassium channel 3 (SK3) is a modulator of endometrial remodeling during endometrial growth.
Lu YC; Yang J; Ding GL; Shi S; Zhang D; Jin L; Pan JX; Lin XH; Zhu YM; Sheng JZ; Huang HF
J Clin Endocrinol Metab; 2014 Oct; 99(10):3800-10. PubMed ID: 24978672
[TBL] [Abstract][Full Text] [Related]
34. Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity.
Kouba S; Braire J; Félix R; Chantôme A; Jaffrès PA; Lebreton J; Dubreuil D; Pipelier M; Zhang X; Trebak M; Vandier C; Mathé-Allainmat M; Potier-Cartereau M
Eur J Med Chem; 2020 Jan; 186():111854. PubMed ID: 31753515
[TBL] [Abstract][Full Text] [Related]
35. Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia.
Figueroa KP; Chan P; Schöls L; Tanner C; Riess O; Perlman SL; Geschwind DH; Pulst SM
Arch Neurol; 2001 Oct; 58(10):1649-53. PubMed ID: 11594924
[TBL] [Abstract][Full Text] [Related]
36. An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia.
Ritsner M; Modai I; Ziv H; Amir S; Halperin T; Weizman A; Navon R
Biol Psychiatry; 2002 May; 51(10):788-94. PubMed ID: 12007452
[TBL] [Abstract][Full Text] [Related]
37. Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation.
Ward S; Simpson E; Davis S; Hind D; Rees A; Wilkinson A
Health Technol Assess; 2007 Oct; 11(40):1-144. PubMed ID: 17903394
[TBL] [Abstract][Full Text] [Related]
38. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
[TBL] [Abstract][Full Text] [Related]
39. New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
Girault A; Haelters JP; Potier-Cartereau M; Chantome A; Pinault M; Marionneau-Lambot S; Oullier T; Simon G; Couthon-Gourvès H; Jaffrès PA; Corbel B; Bougnoux P; Joulin V; Vandier C
Curr Cancer Drug Targets; 2011 Nov; 11(9):1111-25. PubMed ID: 21999627
[TBL] [Abstract][Full Text] [Related]
40. Techniques for the neurological examination of taxane-induced neuropathy.
Ohsumi S; Sunada Y
Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
